Switglim MV 2/0.2 mg Tablet (10 Tab)

Switglim MV 2/0.2 Tablet Overview:

Switglim MV 2/0.2 Tablet is an oral anti diabetic medication, which is used as a third-line treatment for type 2 diabetes mellitus (T2DM). It is prescribed when lifestyle changes, such as diet, exercise, and previous treatment with one or two oral anti diabetic medications, fail to control blood sugar levels effectively. Type 2 diabetes can lead to serious complications, such as heart attack and stroke, as well as kidney damage, nerve damage, vision problems, slow wound healing, etc. Switglim MV 2/0.2 Tablet plays an important role by enhancing the body's response to insulin or increasing the body's production of insulin, thereby reducing the risk of these potentially debilitating symptoms.

Composition of Switglim MV 2/0.2 Tablet:

Each uncoated bilayered tablet contains: Glimepiride 2 mg, Voglibose 0.2 mg, Metformin Hydrochloride (as extended release) 500 mg and Excipients q.s.

Colour: Yellow Oxide of iron.

Uses and Benefits of Switglim MV 2/0.2 Tablet:

Switglim MV 2/0.2 Tablet is used for the treatment of Type II diabetes mellitus or non insulin dependent diabetes mellitus (NIDDM).

How Switglim MV 2/0.2 Tablet Works:

Switglim MV 2/0.2 Tablet is a combination of three oral antidiabetic drugs: glimepiride, voglibose, and metformin. Together, they help improve glycemic control in type II diabetes mellitus patients.

Glimepiride, a sulfonylurea, lowers blood sugar by stimulating the pancreas to release more insulin. Voglibose is an alpha-glucosidase inhibitor that slows the digestion of complex carbohydrates in the small intestine and reduces the rapid rise in blood glucose after meals (postprandial hyperglycemia). Meanwhile, metformin, a biguanide, works by decreasing the liver's glucose production, slowing glucose absorption in the intestines, and enhancing the body's response to insulin.

Dosage of Switglim MV 2/0.2 Tablet:

• Usage Direction

Take Switglim MV 2/0.2 Tablet exactly as your doctor prescribes, and follow the recommended dosage and schedule. Switglim MV 2/0.2 should be swallowed as a whole without crushing, chewing, or breaking it, and ideally at the same time each day. Do not stop or alter the dose of Switglim MV 2/0.2 Tablet without consulting your doctor, as this may prevent you from achieving the desired outcome. Regular monitoring of your blood and urine while taking Switglim MV 2/0.2 Tablet may improve your condition. Ask your doctor or pharmacist to explain any administration procedure you do not understand.

• Missed Dose

If you miss a dose of Switglim MV 2/0.2 Tablet, take it as soon as it is remembered. If it is time for your next dose of Switglim MV 2/0.2 Tablet, skip the missed dose and resume your regular schedule. Avoid taking two doses to compensate for a missed one.

• Overdose

If you accidentally take Switglim MV 2/0.2 Tablet more than your prescribed dose, it may lead to severe hypoglycemia. To manage hypoglycemia on an emergency basis, take fast-acting carbohydrates like sugar, fruit juice, honey, etc and seek medical advice immediately.

Contraindications of Switglim MV 2/0.2 Tablet:

Do not take Switglim MV 2/0.2 Tablet if you are allergic to glimepiride, other sulfonylureas, sulfonamides, metformin, voglibose, or any of its ingredients. This medication should also be avoided if you have Type 1 diabetes, insulin-dependent diabetes, diabetic ketoacidosis, diabetic pre-coma, lactic acidosis, severe kidney or liver dysfunction, acute alcohol intoxication, decompensated heart failure, respiratory failure, recent heart attack, severe infections or trauma, gastrointestinal obstruction, or a tendency for such conditions.

Precautions & Warnings of Switglim MV 2/0.2 Tablet:

Before starting Switglim MV 2/0.2 Tablet, inform your doctor if you are taking any hypoglycemic medications that could increase the risk of cardiovascular mortality. Consult your doctor if you have a history of lactic acidosis, cardiovascular collapse (shock), acute congestive heart failure, acute myocardial infarction, or any conditions linked to hypoxemia, as these have been associated with lactic acidosis.

Side Effects of Switglim MV 2/0.2 Tablet:

Switglim MV 2/0.2 Tablet may also cause some side effects, most of which do not require medical attention and typically go away as your body adapts to the medication. These may include nausea, vomiting, diarrhoea, abdominal pain, heartburn and loss of appetite, blood & lymphatic disorders, metallic taste, abdominal distention, increased flatus and intestinal obstruction. However, if these side effects persist, consult your doctor as soon as possible. Some of the side effects may also be serious and may need medical attention such as; hypoglycaemia, lactic acidosis, eye disorders, etc.

Safety Related Concerns of Switglim MV 2/0.2 Tablet:

• Pregnancy

If you are planning to become pregnant or if a pregnancy is discovered, it's important to consult with your doctor to determine whether it is safe for you to continue with Switglim MV 2/0.2 Tablet. Gestational diabetes, which occurs during pregnancy, carries an increased risk of birth defects. Therefore, your doctor may recommend switching to insulin therapy to better control blood sugar levels. It is essential to monitor blood glucose levels closely throughout pregnancy to minimize the risk of fetal malformations.

• Breastfeeding

Breastfeeding mothers are advised to avoid Switglim MV 2/0.2 Tablet as it may pass through breast milk and can cause side effects in breastfed babies. Therefore, it is important to consult your doctor before taking Switglim MV 2/0.2 while breastfeeding.

• Alcohol

It is recommended to avoid drinking alcohol while taking Switglim MV 2/0.2 Tablet, as it can increase the risk of low blood sugar (hypoglycemia) and may also cause lactic acidosis.

• Food or Interactions with Other Medicines

Carbohydrate-rich foods (such as sugary foods) and high-fat foods should be avoided while taking Switglim MV 2/0.2 Tablet.

Consult your doctor if you are taking any herbal products or supplements while taking Switglim MV 2/0.2 Tablet. As always, please consult your doctor or healthcare provider about your specific dietary needs while on Switglim MV 2/0.2 Tablet.

• Driving:

If you experience side effects such as dizziness or blurred vision, you should avoid driving or operating machinery while taking Switglim MV 2/0.2 Tablet.

Storage Instructions of Switglim MV 2/0.2 Tablet:

Switglim MV 2/0.2 Tablet, should be stored protected from light and moisture, at a temperature not exceeding 30°C.

Keep Switglim MV 2/0.2 Tablet out of reach of children.

Note: Follow the prescribed medicine, regularly monitor blood sugar, maintain a healthy diet and exercise routine, avoid alcohol and smoking, stay hydrated, and manage stress may improve your condition.

Related Blood Glucose Monitors:

To manage diabetes at home, discover our simple, reliable home-use Blood Glucose Monitoring systems with Test Strips. Check Out

Frequently Asked Questions (FAQs) about Switglim MV 2/0.2 Tablet:

1. Is Switglim MV 2/0.2 Tablet used for sugar treatment?

Yes, Switglim MV 2/0.2 Tablet is a combination oral anti-diabetic medication used to manage blood sugar levels by enhancing insulin sensitivity, thereby treating Type 2 diabetes mellitus. It is prescribed when diet, exercise, and one or two other anti-diabetic drugs do not provide sufficient control of blood sugar.

2. Does Switglim MV 2/0.2 Tablet lead to hypoglycemia?

Switglim MV 2/0.2 Tablet is usually recommended for managing Type II diabetes mellitus. However, taking more than the prescribed dose or using it alongside other antidiabetic medications can lead to dangerously low blood sugar levels, a condition known as hypoglycemia.

3. What is the difference between Glycomet GP 2 Tablet and Switglim MV 2/0.2 Tablet?

The primary difference between Glycomet GP 2 Tablet and Switglim MV 2/0.2 Tablet lies in their composition, both of which are used to treat Type II diabetes mellitus. Glycomet GP 2 Tablet combines Glimepiride and Metformin, while Switglim MV 2/0.2 Tablet contains Glimepiride, Voglibose and Metformin. It is essential to take only the medication prescribed by your doctor according to your physical condition and avoid self-medication.

4. What happens if blood sugar drops too quickly?

When blood sugar levels drop too quickly, it can result in hypoglycemia. Symptoms may include shaking or trembling, dizziness, weakness, a rapid heart rate, sweating, and chills. In severe cases, it can cause confusion, seizures, or even coma, which can be life-threatening. To manage hypoglycemia on an emergency basis by consuming fast-acting carbohydrates such as glucose tablets, sugary products, or regular soda to restore blood sugar to normal levels.

5. Is Switglim MV 2/0.2 Tablet an insulin?

No, Switglim MV 2/0.2 Tablet is not an insulin. While insulin is a hormone, Switglim MV 2/0.2 Tablet is a combination of three oral antidiabetic drugs: Glimepiride, Voglibose and Metformin. It is commonly prescribed to individuals with type 2 diabetes to help regulate blood sugar levels.

6. Which food should avoid while taking Switglim MV 2/0.2 Tablet?

While using Switglim MV 2/0.2 Tablet, it is advisable to avoid foods and drinks high in natural or added sugars, such as fruit juice, soda, candy, desserts, white bread, rice, chips, sugary cereals, ice cream, and sweetened milk. Additionally, alcohol should be avoided during this treatment as it can lower blood sugar levels, increasing the risk of hypoglycemia, and may also raise the likelihood of developing lactic acidosis.

7. Can Switglim MV 2/0.2 Tablet cause weight gain?

Yes, Switglim MV 2/0.2 Tablet may cause weight gain due to its ingredient Glimepiride, which belongs to the Sulfonylureas class of medications. Sulfonylureas work by stimulating the pancreas to produce more insulin, which helps lower blood sugar levels. However, insulin also promotes fat storage in the body. As a result, increased insulin levels can lead to the storage of more fat, potentially causing weight gain. If you're concerned about weight gain while taking Switglim MV 2/0.2 Tablet, it is important to discuss it with your healthcare provider. They can adjust your treatment plan to help manage both your blood sugar and weight.

Remarks:

1. Fixed Dose Combinations Approved By DCG (I) From 1st January 2020 to 31st October 2020. Accessed on 31.03.2025. Click Here

2. Diabetes UK. About Diabetes. Accessed on 31.03.2025. Click Here

3. Abridged Prescribing Information. Metformin Hydrochloride (SR), Glimepiride, & Voglibose Tablets. Amaryl MV 1mg. Amaryl MV 2mg. Last Revised on: March 2021. Accessed on 31.03.2025. Click Here

4. Glimitab MV 1/2. Accessed on 31.03.2025. Click Here